Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

The combination of venetoclax with hypomethylating agents (VEN-HMAs) showed promising activity in newly diagnosed and relapsed/refractory (r/r) acute myeloid leukemia (AML). Treatment with VEN-HMAs results in prolonged cytopenia, thereby exposing patients to invasive fungal infections (IFIs). Here,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Aldoss, Ibrahim, Dadwal, Sanjeet, Zhang, Jianying, Tegtmeier, Bernard, Mei, Matthew, Arslan, Shukaib, Al Malki, Monzr M., Salhotra, Amandeep, Ali, Haris, Aribi, Ahmed, Sandhu, Karamjeet, Khaled, Samer, Snyder, David, Nakamura, Ryotaro, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2019
Aiheet:
Myeloid Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963254/
https://ncbi.nlm.nih.gov/pubmed/31816059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000930
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia